Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies

Author： Roovers Rob   Laeremans Toon   Huang Lieven   Taeye Severine   Verkleij Arie   Revets Hilde   Haard Hans   Bergen en Henegouwen Paul M.  

Publisher： Springer Publishing Company

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.56, Iss.3, 2007-03, pp. : 303-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Race, gender and mutations in the prediction of anti-EGFR activity

By Jimeno Antonio  

Future Oncology, Vol. 1, Iss. 2, 2005-04 ,pp. : 201-204

Future Medicine

Access to resources Recommend Favorite

Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs

By Ciardiello F.   Tortora G.  

European Journal of Cancer, Vol. 39, Iss. 10, 2003-07 ,pp. : 1348-1354

Elsevier

Access to resources Recommend Favorite

Predictive markers for anti-EGFR antibodies in colorectal cancer: the beginning of a new era

By Van Cutsem Eric  

Targeted Oncology, Vol. 3, Iss. 4, 2008-10 ,pp. : 223-225

Springer Publishing Company

Access to resources Recommend Favorite

Anti-EGFR Therapy: Strategies in Head and Neck Squamous Cell Carcinoma

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 2, 2016-04 ,pp. : 170-183

Bentham Science Publishers

Access to resources Recommend Favorite

Planning for Intracavitary Anti-EGFR Radionuclide Therapy of Gliomas. Literature Review and Data on EGFR Expression

By J Carlsson   Z.P Ren   K Wester   Å.L Sundberg   N.E Heldin   G Hesselager   M Persson   L Gedda   V Tolmachev   H Lundqvist   E Blomquist   M Nistér  

Journal of Neuro-Oncology, Vol. 77, Iss. 1, 2006-03 ,pp. : 33-45

Springer Publishing Company

Access to resources Recommend Favorite